Novel Therapies for Relapsed and Refractory Neuroblastoma

por Zage, Peter E.
Publicado 2018

Gonadotropin-Dependent Precocious Puberty: Neoplastic Causes and Endocrine Considerations

por Stephen, Matthew D, Zage, Peter E, Waguespack, Steven G
Publicado 2011

The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis

por Adam, Kevin, Lesperance, Jacqueline, Hunter, Tony, Zage, Peter E.
Publicado 2020

USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation

por Le Clorennec, Christophe, Lee, Karen, Huo, Yuchen, Zage, Peter E.
Publicado 2023

UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis

por Le Clorennec, Christophe, Subramonian, Divya, Huo, Yuchen, Zage, Peter E.
Publicado 2023

Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma

por Sen, Arko, Huo, Yuchen, Elster, Jennifer, Zage, Peter E., McVicker, Graham
Publicado 2022

Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression

por Woodfield, Sarah E., Zhang, Linna, Scorsone, Kathleen A., Liu, Yin, Zage, Peter E.
Publicado 2016

Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine

por Du, Michael, Zhang, Linna, Scorsone, Kathleen A., Woodfield, Sarah E., Zage, Peter E.
Publicado 2016

Characterization of G-CSF receptor expression in medulloblastoma

por Paul, Megan Rose, Huo, Yuchen, Liu, Andrea, Lesperance, Jacqueline, Garancher, Alexandra, Wechsler-Reya, Robert J, Zage, Peter E
Publicado 2020

The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma

por Foster, Jennifer H., Barbieri, Eveline, Zhang, Linna, Scorsone, Kathleen A., Moreno-Smith, Myrthala, Zage, Peter, Horton, Terzah M.
Publicado 2021

The multikinase inhibitor RXDX-105 is effective against neuroblastoma in vitro and in vivo

por Flynn, Sean M., Lesperance, Jacqueline, Macias, Andrew, Phanhthilath, Nikki, Paul, Megan Rose, Kim, Jong Wook, Tamayo, Pablo, Zage, Peter E.
Publicado 2019

Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways

por Subramonian, Divya, Phanhthilath, Nikki, Rinehardt, Hannah, Flynn, Sean, Huo, Yuchen, Zhang, Jing, Messer, Karen, Mo, Qianxing, Huang, Shixia, Lesperance, Jacqueline, Zage, Peter E.
Publicado 2020

Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B

por Woodfield, Sarah E., Guo, Rong Jun, Liu, Yin, Major, Angela M., Hollingsworth, Emporia Faith, Indiviglio, Sandra, Whittle, Sarah B., Mo, Qianxing, Bean, Andrew J., Ittmann, Michael, Lopez-Terrada, Dolores, Zage, Peter E.
Publicado 2016

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma

por Lewis, Elizabeth C., Kraveka, Jacqueline M., Ferguson, William, Eslin, Don, Brown, Valerie I., Bergendahl, Genevieve, Roberts, William, Wada, Randal K., Oesterheld, Javier, Mitchell, Deanna, Foley, Jessica, Zage, Peter, Rawwas, Jawhar, Rich, Maria, Lorenzi, Elizabeth, Broglio, Kristine, Berry, Donald, Saulnier Sholler, Giselle L.
Publicado 2020

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

por Sholler, Giselle L. Saulnier, Ferguson, William, Bergendahl, Genevieve, Bond, Jeffrey P., Neville, Kathleen, Eslin, Don, Brown, Valerie, Roberts, William, Wada, Randal K., Oesterheld, Javier, Mitchell, Deanna, Foley, Jessica, Parikh, Nehal S., Eshun, Francis, Zage, Peter, Rawwas, Jawhar, Sencer, Susan, Pankiewicz, Debra, Quinn, Monique, Rich, Maria, Junewick, Joseph, Kraveka, Jacqueline M.
Publicado 2018